- FY2025 loss per share widened to HK0.93 cents.
- FY2025 loss attributable to owners narrowed to HKD 47 million.
- FY2025 revenue dropped 25% to HKD 139 million on lower average selling prices for dental products due to national procurement policy impacts.
- FY2025 gross profit fell to HKD 51 million.
- Management said the revenue decline was driven by PRC centralized procurement price ceilings for dental products.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260325-12067877), on March 25, 2026, and is solely responsible for the information contained therein.
Comments